Apex Capital Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-3,290
Closed -$699K 270
2014
Q4
$699K Sell
3,290
-888
-21% -$177K 0.02% 193
2014
Q3
$744K Sell
4,178
-80
-2% -$13.3K 0.02% 189
2014
Q2
$721K Sell
4,258
-630
-13% -$98.1K 0.02% 194
2014
Q1
$607K Buy
4,888
+170
+4% +$20.7K 0.02% 201
2013
Q4
$524K Hold
4,718
0.02% 200
2013
Q3
$427K Sell
4,718
-51,110
-92% -$4.59M 0.02% 198
2013
Q2
$4.7M Buy
+55,828
New +$5.79M 0.23% 103

Other funds holding AGN

Apex Capital Management's AGN Position: Q1 2015 in Review

Apex Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,290 shares — an estimated $699K sold.

Apex Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.7M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Apex Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Apex Capital Management sold 3,290 Allergan Inc shares in Q1 2015, an estimated $699K.
  • Apex Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Apex Capital Management's Allergan Inc position peaked at $4.7M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Apex Capital Management's 13F filing for Q1 2015, filed 14 Apr 2015.